Labor Market Pulse · Life Sciences · September 2026
Life Sciences Labor Market Report: Honolulu, HI MSA — September 2026
Honolulu's thin talent pool outbids the mainland for biostatisticians.
Honolulu biostatistician pay hit $170,871 against a national median of $133,322, even as regulatory affairs pay slipped to $86,498 and metro unemployment fell to 2.5% on a shrinking, not growing, job base.
Free archive edition. Published by WageScape as sent to subscribers; data as of September 2026.
Key indicators
- Honolulu unemployment rate: 2.5% — Down from 2.7% in August; national rate 4.1%
- Honolulu employment growth: -0.7% — Dec 2024-Dec 2025, despite falling jobless rate
- Biostatistician advertised pay (metro): $170,871 — vs $133,322 national median
- Statewide wage growth rank: 51st — Hawaii avg weekly wage up 1.7% YoY vs national trend
Key takeaways
Biostatistician pay is pulling away from the rest of the market.
Metro median advertised pay for biostatisticians rose to $170,871, outpacing even the national median of $133,322. That divergence, against a backdrop of academic salaries in the $61K-$107K range, suggests Honolulu employers are bidding aggressively for a very thin bench of quantitative talent.
Regulatory affairs pay is softening even as the function gets strategically harder.
Metro Regulatory Affairs Specialist pay fell moderately to $86,498, well below the stable national median of $104,000, even as national commentary points to acute regulatory talent scarcity and VP-level compensation climbing into the $320K-$580K range. Honolulu employers appear under-benchmarked for a function national peers are actively repricing upward.
Clinical research pay is bucking the metro's broader wage malail.
Clinical Research Associate advertised pay in Honolulu rose significantly to $115,190, exceeding the national median of $90,956 despite statewide wage growth ranking near the bottom nationally. Isolated strength here likely reflects a small, highly local clinical trial site pool rather than broad market tightness.
Flat local job growth doesn't mean abundant local candidates.
Honolulu employment fell 0.7% year-over-year even as unemployment dropped to 2.5%, a combination explained by a shrinking labor pool rather than surging demand. Life Sci leaders recruiting for R&D or quality roles should expect longer requisition timelines locally and plan mainland or remote sourcing as a default, not a contingency.
Median advertised pay by role — Honolulu, HI MSA
| Role | 25th percentile | Median advertised pay | 75th percentile | Metro trend | National median |
|---|---|---|---|---|---|
| Research Scientist * | $105,988 | $109,700 | $109,700 | Significant decline | $131,354 |
| Clinical Research Associate | $80,420 | $115,190 | $119,457 | Significant increase | $90,956 |
| Lab Technician | $65,223 | $78,123 | $96,208 | Significant increase | $47,402 |
| Regulatory Affairs Specialist * | $75,074 | $86,498 | $90,471 | Moderate decline | $104,000 |
| Clinical Data Manager * | $113,603 | $120,188 | $125,965 | Significant decline | $123,031 |
| Biostatistician | $129,804 | $170,871 | $175,112 | Significant increase | $133,322 |
| Validation Engineer | — | — | — | No data | $108,377 |
* State-level figure shown where metro postings were too few.
WageScape's median is calibrated to correct for spurious low-value postings (reported as the 60th percentile of raw advertised pay). Download: CSV · JSON
Local market conditions
Honolulu's seasonally adjusted unemployment rate fell to 2.5% in September from 2.7% in August, yet the drop coincides with soft underlying job growth — employment was down 0.7% in the metro over the prior year and overall wage and salary employment remains essentially flat versus 2025. Labor force participation climbed to its highest level since December 2019, a sign that tight headline numbers mask a shallow, slow-growing candidate pool rather than robust hiring momentum.
What it means
Shallow local labor supply, combined with Hawaii's near-total absence of CDMO/pharma manufacturing infrastructure, keeps build-vs-outsource decisions tilted toward CRO and mainland CDMO partnerships for any scale-up in clinical or manufacturing capacity. Wage compression between academic-clinical roles (Queen's Medical Center biostatisticians at $84K-$107K) and advertised private-sector biostatistician pay (metro median $170,871) signals that specialized quantitative and regulatory talent can command sharply higher offers once visible to mainland recruiters — a real outmigration risk. Consider reviewing retention packages for data science, biostatistics, and regulatory affairs roles now, before Q4 budget cycles lock in compensation that no longer reflects the gap between academic and commercial pay.
Looking ahead
Early indicator: Watch whether Hawaii's rising labor force participation (highest since December 2019) translates into more applicants for specialized scientific roles, or whether it reflects workers entering lower-wage service sectors like food service and healthcare support that grew most in 2026.
Emerging pressure point: National biopharma layoffs (BioMarin, Bristol Myers) in September have not yet produced visible Hawaii-specific WARN activity. Monitor whether displaced mainland regulatory or CMC talent becomes newly open to remote or relocation offers tied to Honolulu-based roles.
Worth watching: Hawaii's minimum wage rise to $16.00/hour in January 2026, with $18.00 scheduled for 2028, compresses the gap between entry-level lab technician pay and skilled scientific roles. Expect continued upward pressure on Lab Technician advertised pay, already up significantly to $78,123 locally versus a declining national figure.
Potential inflection point: DBEDT's downgraded 2026 growth forecast (1.3%, down from 2.5% in 2025) suggests softer general hiring ahead. Life Sci leaders should watch whether this translates into reduced competition for lab and research talent from other sectors, potentially easing one source of local wage pressure.
Methodology
Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay. WageScape observes 98% of U.S. job openings daily.
Free to read and cite with attribution to WageScape. Terms of use.